As soon as the genetic testing company 23andMe filed for bankruptcy on March 23, 2025, concerns about what would happen to the personal information contained in its massive genetic and health ...

At its peak, the company was valued at US$6 billion. While the market initially believed in the value of 23andMe’s business model, its stock has been in decline for years, and the company owes ...

If you were a 23andMe customer, your genetic and personal information could be used in civil or criminal cases, targeted ...

The company's market value peaked at almost $6 billion after it went public in 2021, but 23andMe reported a 7% decline in revenue and losses of $174 million in the first nine months of its current ...

At its peak, the company was valued at $6 billion. While the market initially believed in the value of 23andMe's business model, its stock has been in decline for years, and the company owes ...

23andMe is a Silicon Valley-based company which provides ancestry and ... but has since seen a decline in sales over the recent months when the DNA testing craze faded and the company also ...

The company’s market value peaked at almost $6 billion after it went public in 2021, but 23andMe reported a 7% decline in revenue and losses of $174 million in the first nine months of its ...

23andMe announced on the 24th (local ... Macrogen's American subsidiary, Psomagen, is also experiencing a decline in performance. The company is expanding its B2B (business-to-business) operations ...

claims 15 million customers and has seen its sales decline in recent months as the testing craze faded and the company suffered a data breach. 23andMe said that it rejected a takeover offer from ...

claims 15 million customers and has seen its sales decline in recent months as the testing craze faded and the company suffered a data breach. Faced with the difficulties, 23andMe announced the ...

with tests from 23andMe becoming popular holiday gifts. The Silicon Valley-based company, which went public in 2021, claims 15 million customers and has seen its sales decline in recent months as ...